The JAK2 V617F mutation in patients with cerebral venous thrombosis

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

(2011) F. Passamonti et al.   BLOOD

Long-Term Evaluation of the Risk of Recurrence After Cerebral Sinus-Venous Thrombosis

(2010) Ida Martinelli et al.   CIRCULATION

EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients

(2010) K. Einhäupl et al.   EUROPEAN JOURNAL OF NEUROLOGY

JAK2V617F mutation in patients with thrombosis: to screen or not to screen?

(2010) S. G. XAVIER et al.   International Journal of Laboratory Hematology

A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications

(2010) F Passamonti et al.   LEUKEMIA

From Palliation to Targeted Therapy in Myelofibrosis

(2010) Alessandro M. Vannucchi   NEW ENGLAND JOURNAL OF MEDICINE

JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis

(2009) F. Dentali et al.   BLOOD

Low prevalence of the JAK2V617F in patients with ischemic stroke or cerebral venous thrombosis

(2009) Sandra Guerra Xavier et al.   BLOOD COAGULATION & FIBRINOLYSIS

Advances in Understanding and Management of Myeloproliferative Neoplasms

(2009) A. M. Vannucchi et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Blood cell activation in myeloproliferative neoplasms

(2009) F. Cervantes et al.   HAEMATOLOGICA

Update of the guidelines for lupus anticoagulant detection

(2009) V. PENGO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

JAK2-V617F mutation in cerebral venous thrombosis

(2009) K. KOOPMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

TheJAK2V617Fmutation and thrombosis

(2008) S. K. Austin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Antithrombotic Therapy for Venous Thromboembolic Disease

(2008) Clive Kearon et al.   CHEST

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

(2008) V. De Stefano et al.   HAEMATOLOGICA